<DOC>
	<DOCNO>NCT00400855</DOCNO>
	<brief_summary>Inhaling AMP cause inflammatory response lung . This study investigate whether 5-days treatment fluticasone propionate protects lung respond AMP way .</brief_summary>
	<brief_title>Study Effects AMP Challenge Asthmatic Patients Following Treatment With Fluticasone Propionate</brief_title>
	<detailed_description>A randomised , double-blind , placebo-controlled , incomplete block , 4-period crossover study investigate effect 5-day repeat inhaled dose fluticasone propionate ( BID , 50-2000 mcg ) airway responsiveness adenosine-5'-monophosphate ( AMP ) challenge deliver last dose mild asthmatic subject</detailed_description>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Female nonchildbearing potential Using appropriate contraception . Mild asthmatic , non ( ex ) smoker . Has inflammatory response AMP . Otherwise healthy , use steroid . Have history lifethreatening asthma , define asthma episode , require intubation and/or associate either hypercapnea , respiratory arrest hypoxia seizure . Have know sensitivity corticosteroid . Have history milk protein allergy . Test positive screen visit hepatitis B C HIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>AMP challenge</keyword>
</DOC>